Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
No quarterly figures reported.
No quarterly figures reported.
| Fiscal year | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Cash | $2.5K4 | $1.6K2 | $02 | $02 |
| Current assets | $1.6K4 | $02 | $58.3K2 | |
| Total assets | $1.6K4 | $02 | $58.3K2 | |
| Current liabilities | $90.7K4 | $214.3K2 | $444.8K2 | |
| Total liabilities | $90.7K4 | $214.3K2 | $444.8K2 | |
| Shareholders’ equity | -$273.9K4 | -$89.1K2 | -$214.3K2 | -$386.5K2 |
| Shares outstanding | 249.8M shares4 | 249.8M shares4 | 249.8M shares2 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
What it owns
What Nextel Medical Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Investments
Leadership
Who has led Nextel Medical Corp., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerStephen E. Flechner May 24, 2012 to Apr 16, 20135
- PresidentStephen E. Flechner May 24, 2012 to Apr 16, 20135
- Chief financial officerDean Scott Huge May 24, 2012 to Aug 21, 20126
- Chief financial officerDavid J. Cutler Aug 24, 2012 to Apr 16, 20137
Board members and other officers (4)
- Board memberDean Scott Huge May 24, 2012 to Aug 21, 20126
- Board memberRalph Edward Shearing May 24, 2012 to Oct 12, 20128
- Board memberStephen E. Flechner May 24, 2012 to Apr 16, 20135
- Board memberDavid J. Cutler Aug 24, 2012 to Apr 16, 20137
Former names
Timeline
- May 24, 2012New chief executive Stephen E. Flechner becomes CEO5
Filings
35 filings to the SEC since October 2021: 2 quarterly reports, 33 other. The latest 20:
- Sep 4, 2026253G1 OFFERING CIRCULAR RULE 253(G)(1) EDGAR
- Sep 3, 2026QUALIF EDGAR
- Aug 28, 20261-A POS EDGAR
- May 26, 2026253G2 OFFERING CIRCULAR EDGAR
- Mar 27, 2026QUALIF EDGAR
- Mar 27, 2026253G1 EDGAR
- Mar 26, 2026CORRESP EDGAR
- Mar 26, 20261-A POS EDGAR
- Mar 20, 2026CORRESP EDGAR
- Mar 20, 20261-A POS EDGAR
- Mar 18, 2026UPLOAD EDGAR
- Mar 11, 2026CORRESP EDGAR
- Mar 11, 20261-A POS EDGAR
- Mar 5, 2026UPLOAD EDGAR
- Feb 19, 20261-A POS EDGAR
- Feb 11, 2026253G2 OFFERING CIRCULAR EDGAR
- Jan 15, 2026253G2 EDGAR
- Jan 14, 2026253G1 OFFERING CIRCULAR EDGAR
- Jan 7, 2026QUALIF EDGAR
- Dec 31, 20251-A POS EDGAR
The 35 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How Nextel Medical Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARNextel Medical Corp.1
- CIK0001492448
- Employer ID (EIN)27-26165711
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inFlorida1
- Fiscal year endsDecember 311
- Industry code (SIC)4899 Communications Services, NEC1
- SEC reviewing officeOffice of Technology, Division of Corporation Finance1
- Business address7901 4Th Street N #23494, St. Petersburg, FL 337021
- Phone509-605-65331
- Shares outstanding249,843,977 as of Sep 21, 20209
- Public float$63.7M as of Oct 31, 20192
- On EDGAR sinceJun 3, 20101
- Filings174 in all: 8-K (25), CORRESP (19), 4 (18), UPLOAD (18), 10-Q (16), NT 10-Q (8), 3 (7), 8-K/A (7)1
All 29 form types
1-A POS (6), 10-Q/A (6), 253G2 (5), NT 10-K (5), S-1/A (5), 10-K (4), 253G1 (4), QUALIF (4), 1-A/A (2), 144 (2), 15-12G (2), 424B3 (2), 1-A (1), 10-12G (1), 10-12G/A (1), 8-A12G (1), EFFECT (1), NT 10-Q/A (1), S-1 (1), S-8 (1), SC 13G (1)
- Latest filingsAnnual report (10-K) Aug 13, 2020
Quarterly report (10-Q) Jul 29, 2022
Latest 8-K (8-K) Dec 11, 2020
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARRalph Edward Shearing, Board member
- 9